Which ETFs Am I Most Confident Investing In? Confidence Ratings 1–100
If you've ever stared at a brokerage screener with 500+ ETF tickers and thought, "okay, but which of these actually deserve my money?" — you're exactly who this series is for. I pulled a dataset of ETFs with their core valuation and growth metrics, sorted through it methodically, and I'm going to walk you through exactly which funds rise to the top of my personal confidence list, and more importantly, why.
This is not financial advice — think of it as me showing my work. I'll explain the framework I use to score confidence, break down the metrics that matter most, and then start naming names. By the end of this series (6–10 parts), you'll have a fully ranked list of ETFs across categories — value, emerging markets, dividend growth, small-cap, international — each with a confidence score and the reasoning behind it.
📋 Table of Contents
- Part 1: The Confidence Rating Framework (You Are Here)
- Part 2: Top Value ETFs — Deep Discount, High Confidence
- Part 3: Emerging Markets ETFs Worth Watching
- Part 4: Dividend & Cash Flow Kings
- Part 5: Small-Cap and Mid-Cap Value Standouts
- Part 6: International Developed Markets Picks
- Part 7: Sector & Thematic Plays Worth the Risk
- Part 8: The ETFs I'm Avoiding (Low Confidence List)
- Part 9: Building a Portfolio From the High-Confidence List
- Part 10: Final Rankings, FAQs & Closing Thoughts
1. Why "Confidence Ratings" Instead of Just "Buy/Sell"
Most ETF content online falls into two lazy buckets: hype ("10 ETFs to buy NOW!") or paralysis-inducing spreadsheets with no interpretation. I wanted something in between — a transparent, repeatable scoring system that tells you not just what I'd invest in, but how strongly I believe in it.
A confidence rating of 90+ means the fundamentals are screaming "undervalued and growing." A rating in the 40s means it's fine, but nothing special — maybe a fund I'd hold a small position in, not build a portfolio around. Anything below 30 means I'd need a very specific reason (like sector diversification) to touch it at all.
The Six Metrics I'm Weighing
| Metric | What It Tells Us | Weight in My Score |
|---|---|---|
| Price/Earnings (P/E) | How expensive the fund is relative to underlying profits | 25% |
| Price/Sales (P/S) | Valuation relative to revenue — useful across cycles | 15% |
| Price/Book (P/B) | Valuation relative to net assets — classic "value" signal | 15% |
| Sales Growth | Is the underlying business actually growing? | 15% |
| Cash Flow Growth | Quality of earnings — cash doesn't lie the way accounting profits can | 15% |
| Book Value Growth | Is shareholder equity compounding over time? | 15% |
No single metric tells the whole story. A fund with a rock-bottom P/E but shrinking sales and flat cash flow is often a value trap, not a value opportunity. What I'm really hunting for is the sweet spot: low valuation multiples paired with real, durable growth. That combination is rare, and when I find it in this dataset, that's where the confidence scores spike.
2. The Trap of "Cheap for a Reason"
Scanning any large ETF dataset sorted by P/E, you'll immediately notice something: the very cheapest funds by P/E tend to cluster around specific themes — emerging market bonds, single-country funds (Brazil, China, South Africa), and leveraged/inverse products. That's not a coincidence. Markets price in risk, and geographic concentration risk, currency risk, and political risk all show up as a discount.
This is why my framework leans hard on the growth trio (sales, cash flow, book value) alongside valuation. A fund like a Brazil small-cap ETF might show an eye-catching P/E under 9, but if cash flow growth is inconsistent or sales growth is anemic, that "cheapness" isn't really an edge — it's just risk without adequate compensation.
What Actually Moves the Needle Toward High Confidence
- Consistency across metrics — I trust funds where P/E, P/S, and P/B are all reasonably low, not just one outlier number.
- Real growth, not statistical noise — some funds in the dataset show wild growth numbers (triple digits) that are usually the result of a small base or one-time event, not sustainable compounding.
- Diversified underlying exposure — broad multi-country or multi-sector funds tend to earn higher confidence than single-country bets, all else equal.
- Category leadership — established fund families (Vanguard, iShares, Avantis, Dimensional, WisdomTree, Schwab) with strong index methodology and liquidity get a small trust bump over obscure niche issuers.
3. A Sneak Peek: The Early Standouts
Without giving away the full rankings (that's coming in Parts 2 through 8), I can tell you the shape of what's emerging from this data. The highest-confidence names cluster into a few recognizable families:
- Broad-based U.S. small-cap value funds (think Avantis, Dimensional, Vanguard) — consistently reasonable multiples with real growth underneath.
- "Cash cow" / free-cash-flow-focused ETFs — funds explicitly screening for strong free cash flow generation tend to combine low P/S with strong cash flow growth, a combination I weight heavily.
- Select emerging market value funds — not the single-country ones, but diversified, factor-based EM funds that balance the discount with genuine growth.
- Quality dividend growth funds — less flashy, but the combination of reasonable book value multiples and steady growth earns steady, if not spectacular, confidence scores.
What's not making the high-confidence cut, at least based on early analysis: leveraged and inverse products (great for trading, terrible for "confidence" in the buy-and-hold sense), and funds where a single blowout growth number is masking otherwise mediocre fundamentals across the board.
4. What's Coming Next
In Part 2, we get into the specifics: I'll name the exact value ETFs earning confidence scores in the 80–95 range, walk through their P/E, P/S, P/B, and growth numbers side by side, and explain the reasoning behind each score. From there, we'll move category by category — emerging markets, dividend/cash-flow funds, small-caps, international developed markets, and thematic plays — before wrapping up with a full ranked table and a sample high-confidence portfolio.
5. Top Value ETFs: My Highest-Confidence Picks
These are diversified, well-run value funds — not single-country bets, not leveraged products, not niche themes. Just funds that combine a genuine valuation discount with growth numbers that suggest the discount isn't a trap. I'm ranking these on my 1–100 confidence scale, and I'll explain the "why" behind every score.
This is one of the cleanest stories in the entire dataset. COWZ screens explicitly for companies with the strongest free cash flow yield, and it shows: a 13%+ cash flow growth rate paired with a reasonable P/S under 1.3 is a rare and genuinely attractive combination. Free cash flow is the metric that's hardest to fake with accounting tricks, which is exactly why I weight it heavily. This is a fund I'd anchor a portfolio around.
A sub-12 P/E on a diversified U.S. equity fund is genuinely rare, and QVAL backs it up with strong book value growth near 10% and healthy cash flow growth. This is a concentrated, actively-managed quant value strategy, so it will be more volatile than a broad index fund — but the fundamental combination here is one of the strongest in the entire dataset.
AVUV is one of the most respected small-cap value funds available, run by Avantis using Dimensional-style factor investing. The valuation multiples here are excellent across the board — low P/E, low P/S, low P/B all at once, which is the consistency I look for. Growth is more modest than COWZ or QVAL, which is why it lands just below them, but the sheer valuation discount combined with a trusted, liquid, well-diversified structure keeps this near the top of my list.
"Pure" value indexes like this one deliberately concentrate in the most statistically cheap large-cap names rather than diluting with blend-y holdings. The result is a rock-bottom Price/Sales ratio of 0.6 alongside solid, well-rounded growth across all three growth metrics. This is a large-cap-focused complement to the small-cap tilt of AVUV — I like holding both.
DSTL's P/E is higher than the others on this list, but I still rate it highly because of what's driving that price: real, strong growth across the board — nearly 9% sales growth and 12% cash flow growth. Distillate's methodology specifically screens out companies with distorted valuations due to high debt loads, which is a quality layer that doesn't show up directly in these six metrics but adds to my confidence.
Honorable Mentions (Confidence 75–80)
| Ticker | Fund | P/E | Confidence | Why |
|---|---|---|---|---|
| AVLV | Avantis US Large Cap Value | 18.88 | 79 | Higher multiples, but growth (7–10% across the board) justifies it |
| VFVA | Vanguard U.S. Value Factor | 13.69 | 78 | Great valuation, but growth metrics are the weakest link |
| SYLD | Cambria Shareholder Yield | 13.02 | 76 | Cheap and shareholder-friendly, but sales growth is nearly flat |
| DFLV | Dimensional US Large Cap Value | 19.39 | 75 | Solid all-around, nothing exceptional to push it higher |
6. What Separates an 85 from a 95?
You'll notice nothing in this batch scored above 88. That's intentional — I'm holding my highest tier (90+) for funds where every single metric lines up, with no weak link at all. So far in the U.S. value space, even the best funds have at least one metric (usually cash flow or sales growth) that's merely "good" rather than "exceptional." As we move into other categories in the coming parts — particularly cash-flow-focused funds and select emerging market value plays — we'll see whether any funds can break into that rarified 90+ tier.
Up next in Part 3, we head overseas: emerging markets ETFs. This category has some of the lowest P/E ratios in the entire dataset, but also the widest range of outcomes — from genuinely undervalued diversified funds to risky single-country bets dressed up as "bargains." I'll separate the two.
7. Emerging Markets: Where "Cheap" Gets Complicated
Scroll through any ETF screener sorted by P/E, and emerging market and single-country funds dominate the bottom (cheapest) end. That's not because these markets are secretly the best investments on Earth — it's because investors demand a discount for currency risk, political risk, and less mature capital markets. My job in this section is separating funds where that discount is excessive relative to the growth on offer, from funds where the discount is just fair compensation for real risk.
8. High-Confidence Emerging Markets ETFs
A 21% cash flow growth rate on a fund with an 11.26 P/E is an outstanding combination, and it's the same free-cash-flow screening methodology that made COWZ my top U.S. pick in Part 2. Applying that same discipline to emerging markets — screening specifically for companies generating strong, growing free cash flow rather than just "cheap" companies — produces one of the best risk-adjusted profiles in the entire EM category. Sales growth is the one soft spot here, but the cash flow strength more than compensates.
Same trusted issuer as AVUV from Part 2, applied to diversified emerging markets. The valuation multiples are excellent across the board and cash flow growth near 12% is strong. Avantis funds also tilt toward profitability within the value universe, which historically has helped avoid the worst "cheap but deteriorating" traps — a quality dimension not directly visible in these six numbers but reflected in the fund's live track record.
JPEM's diversified-return methodology explicitly reduces concentration risk relative to cap-weighted EM indexes, spreading exposure more evenly across countries and sectors. Combined with a low-12 P/E and the best book value growth of this group (8.27%), it earns a solid spot without any glaring weak point — a consistent, well-rounded profile rather than one standout metric.
Solid but Not Exceptional (Confidence 74–80)
| Ticker | Fund | P/E | Confidence | Why |
|---|---|---|---|---|
| EYLD | Cambria EM Shareholder Yield | 10.6 | 79 | Very cheap, decent growth, but a less liquid niche issuer |
| AVEM | Avantis Emerging Markets Equity | 15.44 | 78 | Broader (less value-tilted) than AVES, still solid growth |
| DFEV | Dimensional EM Value | 14.12 | 77 | Well-diversified and disciplined, but growth is middling |
| FNDE | Schwab Fundamental EM Equity | 11.35 | 75 | Great valuation, but sales/cash flow growth are the weakest of the group |
9. The Single-Country "Value Trap" Watchlist
Now for the caution flags. Several single-country and leveraged EM funds show the lowest P/E ratios in the entire dataset — but I'm rating these low-to-moderate confidence despite the tempting valuations, because the discount reflects real, concentrated risk that a diversified fund simply doesn't carry.
- BRF (VanEck Brazil Small-Cap): P/E 8.33 looks like a steal, but single-country small-cap exposure to Brazil carries currency and political risk that isn't reflected in these multiples. Confidence: 52.
- FXI (iShares China Large-Cap): P/E 8.76 with decent growth, but regulatory unpredictability around Chinese equities keeps this out of my high-confidence tier. Confidence: 54.
- YINN (Direxion Daily FTSE China Bull 3X): Same underlying exposure as FXI, but leveraged 3x — this is a trading vehicle, not a buy-and-hold confidence pick. Confidence: 22.
- EZA (iShares MSCI South Africa): P/E 9.16 and strong cash flow growth (17%), but concentrated single-country political and currency risk caps my confidence. Confidence: 58.
- EPHE (iShares MSCI Philippines): Reasonable growth numbers, but thin liquidity and single-country concentration. Confidence: 51.
10. Looking Ahead
Emerging markets gave us our first fund to crack the high-80s (ECOW at 87), driven almost entirely by an exceptional cash flow growth number. That's a pattern I expect to see again in Part 4, where we turn to dividend and cash-flow-focused ETFs specifically — a category built around exactly the kind of metric that's been separating the good funds from the great ones so far.
11. Why Free Cash Flow Beats Dividend Yield
A lot of income-focused investors default straight to dividend yield as their main screen. I don't. Yield is backward-looking and easy to manipulate — a falling stock price mechanically pushes yield up, which is exactly the opposite of what you want. Free cash flow, on the other hand, measures the actual cash a business generates after covering its operating and capital expenses. It's the fuel behind dividends, buybacks, and debt paydown — and it's much harder to fake.
That's why the "cash cow" and "free cash flow" fund families keep showing up near the top of my confidence rankings. They're not screening for the highest current yield; they're screening for the businesses generating the most real cash relative to their price, which is a fundamentally more durable signal.
12. High-Confidence Dividend & Cash Flow ETFs
This is the highest score we've seen in the series so far. A P/E under 14, a Price/Sales under 0.9, and cash flow growth over 15% is about as close to "everything lines up" as this dataset gets. There's no glaring weak spot anywhere in the six metrics — this is the definition of the sweet spot I described back in Part 1.
Nearly identical profile to FLOW — low valuation, strong cash flow growth — but with the added benefit of pulling exclusively from the S&P 500, meaning higher-quality, more liquid, large-cap holdings. Sales growth here (8.75%) is actually the best of this entire dividend/cash-flow category, though book value growth lags a bit, which is what keeps it just behind FLOW.
Slightly pricier on P/E and P/B than FLOW or FCFY, but the growth story here is arguably the most balanced of the three: sales growth over 9%, cash flow growth over 10%, and book value growth over 8%. When all three growth metrics are strong simultaneously, I'm willing to tolerate a somewhat higher valuation multiple — that's exactly the trade-off happening here.
A fund-of-funds structure that blends multiple Pacer "Cash Cows" strategies (U.S., global, small-cap) into one ticker. That extra layer of diversification across cash-flow strategies is appealing, and the underlying fundamentals are consistently solid, if not quite as exceptional as the pure-play, single-strategy funds above it.
Solid across the board with the best book value growth of this group at 9.33%, but the Price/Sales ratio is noticeably higher than its peers here, and cash flow growth — the metric this whole fund category is named after — is actually the weakest link relative to FLOW, FCFY, and VFLO. Still a reasonable holding, just not a standout.
Traditional Dividend ETFs: Solid, Not Spectacular
It's worth pausing on something notable: the classic, well-known dividend index funds — the ones most investors already own — actually score lower than these newer cash-flow-focused funds under this framework. That's not a knock on their quality; it's a reflection of the fact that price appreciation over time has pushed their valuation multiples higher relative to underlying growth.
| Ticker | Fund | P/E | Confidence | Why |
|---|---|---|---|---|
| SCHD | Schwab U.S. Dividend Equity | 18.29 | 78 | Excellent long-term track record and liquidity, but multiples have run up |
| DIVB | iShares Core Dividend | 16.76 | 74 | Balanced but unremarkable growth profile |
| RDIV | Invesco S&P Ultra Dividend Revenue | 12.21 | 72 | Cheap, but sales growth is nearly flat at 0.84% |
| DVY | iShares Select Dividend | 15.50 | 69 | Weak cash flow growth (1.5%) drags down an otherwise fine fund |
13. Category Leaderboard So Far
Three parts in, here's how the top of the overall list is shaping up:
- FLOW — 89
- COWZ — 88
- ECOW — 87
- QVAL — 86
- FCFY — 86
- AVUV — 85
- VFLO — 85
Notice the theme: every fund in the current top tier either screens explicitly for free cash flow or combines a genuine valuation discount with strong, verifiable growth. In Part 5, we shift to small-cap and mid-cap value specifically — a category with some interesting outliers, including a few funds with unusually strong book value growth that deserve a closer look.
14. Why Small and Mid-Cap Value Deserves Its Own Category
Small and mid-cap companies tend to get overlooked because they're less familiar, less covered by analysts, and often more volatile day to day. But that same neglect is exactly why this corner of the market frequently trades at a discount to large-caps — and why disciplined stock selection within it can uncover some of the best combinations of valuation and growth in the entire dataset. Two names below back this up directly.
15. High-Confidence Small & Mid-Cap Picks
This is the small-cap sibling of VFLO from Part 4, and it might be even more impressive: a sub-13 P/E paired with 15%+ cash flow growth and over 8% book value growth. Every single growth metric here is strong at once, which is exactly the "no weak link" profile that pushes a score toward the high 80s. If you want cash-flow discipline applied specifically to smaller companies, this is the cleanest option in the dataset.
The lowest P/E of any diversified U.S. small/mid-cap fund on this list, combined with a cash flow growth rate over 17%. This is a smaller, more actively managed fund than most others on this list, which adds a layer of manager-risk that a passive index fund doesn't carry — that's the main reason it sits just behind SFLO rather than ahead of it, despite arguably stronger raw numbers.
A genuinely well-rounded profile — every growth metric sits comfortably between 7–9%, and the valuation multiples are all reasonable without being extreme outliers in either direction. This kind of consistency across all six data points is exactly what earns a fund a spot in the low 80s even without one single headline-grabbing number.
One of the cheapest mid-cap funds in the entire dataset by P/E, P/S, and P/B simultaneously. Growth is more modest than SFLO or RNIN — sales and cash flow growth both sit in the 4–5% range — but the valuation discount is deep enough that I'm still comfortable rating this in the low 80s. AlphaDEX's enhanced-indexing methodology (screening on growth and value factors rather than simple cap-weighting) also adds a layer of active discipline.
Solid Options (Confidence 72–78)
| Ticker | Fund | P/E | Confidence | Why |
|---|---|---|---|---|
| XMVM | Invesco S&P MidCap Value w/ Momentum | 12.71 | 76 | Cheap, but sales & cash flow growth both under 3% |
| AVMV | Avantis U.S. Mid Cap Value | 17.43 | 75 | Trusted issuer, decent growth, but pricier than peers here |
| FDM | First Trust Dow Jones Select MicroCap | 12.94 | 74 | Cheap, but micro-cap liquidity risk and modest growth |
| VOE | Vanguard Mid-Cap Value Index | 18.85 | 72 | Rock-solid and liquid, but valuation has drifted higher |
16. Updated Leaderboard
- FLOW — 89
- COWZ — 88
- ECOW — 87
- SFLO — 87
- QVAL — 86
- FCFY — 86
- AVUV — 85
- RNIN — 85
- VFLO — 85
The small-cap free-cash-flow story (SFLO) just cracked the top tier, reinforcing a pattern that's now shown up in three separate categories: whenever a fund explicitly screens for cash flow generation and maintains a low valuation, it tends to land near the top regardless of market cap or geography. In Part 6, we head to international developed markets — Japan, Europe, and diversified developed-ex-US funds — to see if that same pattern holds up outside the U.S.
17. Developed Markets: Cheaper Than the U.S., But Why?
International developed market ETFs — Japan, Europe, the broad EAFE universe — have traded at persistent valuation discounts to U.S. equities for over a decade. Some of that is structural (different sector composition, less concentration in high-growth tech), and some of it reflects genuinely slower growth. My job here is the same as it was with emerging markets: find where the discount is being adequately compensated by real growth, and where it's just a slow-growth market being correctly priced as such.
18. High-Confidence International Developed Picks
The best balance in the entire international developed category — a P/E just above 12 alongside consistent, if unspectacular, growth across all three growth metrics. AlphaDEX's enhanced-index screening (weighting on growth and value factors rather than simple market cap) shows up clearly here: this isn't just "cheap because it's foreign," it's cheap with real fundamental support behind it.
Sales growth is the weak point here at just 1.26%, but a cash flow growth rate over 12% on a fund trading under a 14 P/E is hard to ignore. This gives diversified exposure across developed Asia-Pacific markets (excluding Japan, which we cover separately below), spreading out the single-country risk that hurt several Asian funds back in Part 3.
The best pure-Japan play in the dataset. Japan has been in the middle of a genuine corporate governance and shareholder-return renaissance over the past few years, and this fund's numbers reflect that story well: solid growth across all three metrics, topped off by the strongest book value growth (8.83%) of any international fund on this list.
A small-cap dividend-weighted approach to the same Japan story as FJP, with an even cheaper Price/Book ratio. Small-cap Japan brings slightly more liquidity and currency-hedging considerations to think about, which is why it sits just behind FJP despite a comparably strong fundamental profile.
Cheap, But With Caveats (Confidence 65–76)
| Ticker | Fund | P/E | Confidence | Why |
|---|---|---|---|---|
| FDTS | First Trust Developed Markets ex-US Small Cap AlphaDEX | 9.55 | 76 | The lowest P/E in this category, but growth across the board is only modest |
| IPKW | Invesco Intl BuyBack Achievers | 12.59 | 73 | Shareholder-friendly screen, but cash flow growth is weak at 1.79% |
| FGM | First Trust Germany AlphaDEX | 11.40 | 70 | Very cheap, but book value growth is nearly flat (0.70%) and single-country |
| FEP | First Trust Europe AlphaDEX | 13.48 | 64 | Cash flow growth essentially flat (0.22%) — cheap for a reason |
19. Updated Leaderboard
- FLOW — 89
- COWZ — 88
- ECOW — 87
- SFLO — 87
- QVAL — 86
- FCFY — 86
- AVUV — 85
- RNIN — 85
- VFLO — 85
- FDT — 84
International developed markets confirmed the pattern one more time: FDT's balanced, no-weak-link profile earns a respectable 84, but nothing in this category challenges the free-cash-flow leaders from Parts 2 and 4. In Part 7, we shift gears into sector and thematic ETFs — insurance, financials, homebuilders, and a few unexpected niches where the numbers get genuinely interesting.
20. Sector Funds: A Different Kind of Risk
Sector ETFs trade broad diversification for concentrated exposure to a single industry's cycle. That means my confidence bar here is naturally a bit higher than for diversified funds — I want to see not just good numbers, but numbers strong enough to compensate for the added cyclicality. A few sectors clear that bar convincingly; others look cheap for reasons that become obvious once you dig in.
21. High-Confidence Sector & Thematic Picks
Insurance is one of the most underrated sectors in this entire dataset. A sub-11 P/E with 7.7% sales growth and nearly 13% book value growth (insurers build book value through underwriting profit and investment income) is an outstanding combination. Cash flow growth is weak here, but for insurers, book value growth is arguably the more relevant metric anyway, since it reflects growing reserves and capital strength.
Nearly identical story to IAK, just equal-weighted instead of cap-weighted, which gives more exposure to smaller insurers. Sales growth here is actually the strongest of the two at 8.74%. If you already own IAK, KIE is largely redundant; if you're choosing one, the two are close enough that it mostly comes down to preference for cap-weighting versus equal-weighting.
"GARP" stands for Growth At a Reasonable Price, and this fund lives up to the name: every single growth metric is in double digits — sales growth near 12%, cash flow growth near 20%, book value growth near 16%. Yes, the P/B multiple is higher than most funds on this list, but when growth is this strong and this consistent across all three metrics, I'm comfortable paying up for it.
Another cash-flow-screened fund, this one values-based (faith-aligned screening) with a smaller, more concentrated portfolio. Book value growth of 13.19% stands out, and the rest of the growth profile is solid, though the P/E here is higher than the other free-cash-flow funds we've covered — a reasonable trade-off given the strength of the growth numbers.
Solid Sector Plays (Confidence 70–78)
| Ticker | Fund | P/E | Confidence | Why |
|---|---|---|---|---|
| KCE | SPDR S&P Capital Markets ETF | 19.34 | 76 | Sales growth near 15%, but valuation is the highest of this group |
| FXD | First Trust Consumer Discretionary AlphaDEX | 14.88 | 73 | Balanced, but tied to consumer spending cyclicality |
| ITB | iShares U.S. Home Construction ETF | 17.08 | 68 | Highly cyclical, rate-sensitive sector; cash flow growth weak |
| COPX | Global X Copper Miners ETF | 17.19 | 65 | Commodity-price-driven earnings make this metric set less reliable |
22. A Data Trap Worth Calling Out
This is exactly the kind of trap I flagged back in Part 1 — a standout number that looks like a screaming buy signal but is actually a reason for skepticism. GAA (Cambria Global Asset Allocation ETF) shows a similar issue with a reported 1,123% sales growth figure — another statistical artifact rather than a real signal, and another fund I'm not rating highly despite the eye-popping number.
23. Updated Leaderboard
- FLOW — 89
- COWZ — 88
- ECOW — 87
- SFLO — 87
- IAK — 86
- QVAL — 86
- FCFY — 86
- AVUV — 85
- RNIN — 85
- VFLO — 85
Insurance (IAK) just broke into the top tier — proof that unglamorous, unloved sectors can hide some of the strongest fundamentals in the whole market. In Part 8, we flip the script entirely: the low-confidence list. I'll walk through the ETFs I'd avoid or approach with real caution, and explain exactly what in the numbers is driving that skepticism.
24. Why "Low Confidence" Doesn't Always Mean "Bad Fund"
Before naming names, one important distinction: a low score on my scale doesn't mean the fund is poorly constructed or that nobody should own it. It means the fund doesn't fit this specific framework — a search for funds combining low valuation with genuine, verifiable growth. Some low-confidence funds here are excellent for entirely different purposes: short-term trading, hedging, or tactical exposure. Others, though, are genuine value traps or funds whose "cheapness" is a red flag rather than an opportunity.
25. Category One: Leveraged & Inverse Products
The underlying index metrics here are identical to FXI, but 3x daily leverage means this fund is built for short-term trading, not buy-and-hold investing. Daily rebalancing causes volatility decay that erodes returns over time even if the underlying index is flat — a mathematical reality that makes "confidence" as a long-term holding essentially meaningless for this product category.
26. Category Two: Statistical Artifacts
These growth numbers look spectacular at first glance, but Turkey has experienced extreme currency devaluation and high domestic inflation in recent years. Nominal growth figures like these get inflated by inflation itself — a company can show 40%+ "growth" in local currency terms while producing roughly the same real output. This is a textbook example of why I never take a single flashy number at face value.
27. Category Three: Cheap Without Compensation
Every valuation multiple here looks reasonable in isolation, but every growth metric is weak. This is the classic value-trap pattern: a market pricing in genuinely low expectations, and the fundamentals confirming those low expectations are justified rather than overly pessimistic. Cheap, but for a reason.
| Ticker | Fund | P/E | Confidence | Why |
|---|---|---|---|---|
| JHID | John Hancock Intl High Dividend | 14.12 | 44 | Sales growth 1.11%, cash flow growth 0.99% — nearly stagnant |
| PEY | Invesco High Yield Equity Dividend Achievers | 14.14 | 41 | Sales growth just 0.11% — high yield may not be sustainable |
| HEDJ | WisdomTree Europe Hedged Equity | 18.81 | 39 | Higher valuation and weak sales growth (0.93%) — worst of both worlds |
28. Category Four: Niche & Thinly-Traded Products
A handful of smaller, newer, or more obscure funds show attractive metrics on paper but carry structural risks these six numbers can't capture — low trading volume, wide bid-ask spreads, short track records, or concentrated single-strategy risk from tiny issuers. I'm not naming specific tickers here as "bad," because the underlying fundamentals in some cases are genuinely fine — but I'd rate any fund with limited assets under management and thin daily volume at least 10–15 points lower than an identical-fundamentals fund from an established, liquid issuer, purely on structural-risk grounds.
29. Looking Ahead
Now that we've covered both ends of the spectrum — the high-confidence leaders across value, emerging markets, cash flow, small/mid-cap, international, and sector categories, plus the funds I'd avoid — Part 9 puts it all together. I'll build a sample high-confidence portfolio using the top-rated names from across every category, with suggested allocation weights and the reasoning behind the mix.
30. Full Confidence Leaderboard (Top 15)
| Rank | Ticker | Fund | Category | Confidence |
|---|---|---|---|---|
| 1 | FLOW | Global X U.S. Cash Flow Kings 100 | US Cash Flow | 89 |
| 2 | COWZ | Pacer US Cash Cows 100 | US Cash Flow | 88 |
| 3 | ECOW | Pacer EM Cash Cows 100 | Emerging Markets | 87 |
| 4 | SFLO | VictoryShares Small Cap Free Cash Flow | Small/Mid Cap | 87 |
| 5 | IAK | iShares U.S. Insurance | Sector | 86 |
| 6 | QVAL | Alpha Architect US Quant Value | US Value | 86 |
| 7 | FCFY | First Trust S&P 500 Diversified FCF | US Cash Flow | 86 |
| 8 | AVUV | Avantis US Small Cap Value | Small/Mid Cap | 85 |
| 9 | RNIN | Bushido Capital US SMID Cap Equity | Small/Mid Cap | 85 |
| 10 | VFLO | VictoryShares Free Cash Flow | US Cash Flow | 85 |
| 11 | FDT | First Trust Developed Mkts Ex-US AlphaDEX | International | 84 |
| 12 | AVES | Avantis Emerging Markets Value | Emerging Markets | 84 |
| 13 | KIE | SPDR S&P Insurance | Sector | 84 |
| 14 | RPV | Invesco S&P 500 Pure Value | US Value | 84 |
| 15 | DSTL | Distillate US Fundamental Stability & Value | US Value | 83 |
31. Building the Allocation: My Approach
A portfolio isn't just "buy the top 10 by score." Even within a high-confidence list, I want genuine diversification across market cap, geography, and strategy — otherwise you're just concentrating multiple funds around the same underlying risk factor (in this case, largely U.S. free-cash-flow exposure). Here's how I'd translate the leaderboard into an actual allocation, grouped by role rather than raw rank.
Core Holdings (55% combined) — The Highest-Conviction, Most Diversified Names
FLOW and COWZ anchor the portfolio because they scored highest overall and hold hundreds of diversified large-cap names — low single-stock risk, broad sector spread, and the strongest fundamental combination in the dataset. AVUV adds small-cap value tilt (a factor with strong long-term historical premium), and FDT provides genuine international diversification, reducing home-country concentration.
Satellite Holdings (30% combined) — Targeted, Higher-Conviction Bets
| Ticker | Weight | Role in Portfolio |
|---|---|---|
| ECOW | 8% | Emerging markets exposure via free-cash-flow screen, avoiding single-country risk |
| IAK | 7% | Sector tilt toward an underrated, high-book-value-growth industry |
| SFLO | 8% | Small-cap cash flow exposure, complementing AVUV's value-only tilt |
| QVAL | 7% | Concentrated quant value for higher-conviction, higher-volatility upside |
Diversifiers (15% combined) — Lower Correlation to the Core
| Ticker | Weight | Role in Portfolio |
|---|---|---|
| FJP | 8% | Direct Japan exposure — corporate governance tailwinds, low correlation to US cash-flow factor |
| DSTL | 7% | Debt-quality screen adds a different risk lens than pure valuation/growth |
32. What This Allocation Is Optimizing For
This isn't a maximally aggressive, chase-the-highest-score portfolio — it's built for someone who wants meaningfully above-average fundamentals while still maintaining real diversification. If you wanted a more concentrated, higher-conviction (and higher-volatility) version, you could reasonably overweight FLOW, COWZ, and QVAL further and trim the diversifier sleeve. If you wanted something more conservative, you could add a slice of a broad, ultra-liquid core fund like IEFA or a total-market index alongside this list to dampen factor-concentration risk even further.
33. Looking Ahead: The Final Part
In Part 10 — the final installment — I'll pull together the complete ranked table across every ETF discussed in this series, answer some anticipated FAQs (rebalancing frequency, tax considerations, how often I'd revisit these scores), and close out with some final thoughts on how to use a framework like this one responsibly.
34. The Complete Ranked List
Here's every ETF discussed across all nine analytical parts of this series, ranked by confidence score. This isn't every fund in the original dataset — it's the ones that stood out enough, in either direction, to be worth writing about.
| Rank | Ticker | Fund | Confidence |
|---|---|---|---|
| 1 | FLOW | Global X U.S. Cash Flow Kings 100 | 89 |
| 2 | COWZ | Pacer US Cash Cows 100 | 88 |
| 3 | ECOW | Pacer EM Cash Cows 100 | 87 |
| 4 | SFLO | VictoryShares Small Cap Free Cash Flow | 87 |
| 5 | IAK | iShares U.S. Insurance | 86 |
| 6 | QVAL | Alpha Architect US Quant Value | 86 |
| 7 | FCFY | First Trust S&P 500 Diversified FCF | 86 |
| 8 | AVUV | Avantis US Small Cap Value | 85 |
| 9 | RNIN | Bushido Capital US SMID Cap Equity | 85 |
| 10 | VFLO | VictoryShares Free Cash Flow | 85 |
| 11 | FDT | First Trust Developed Mkts Ex-US AlphaDEX | 84 |
| 12 | AVES | Avantis Emerging Markets Value | 84 |
| 13 | KIE | SPDR S&P Insurance | 84 |
| 14 | RPV | Invesco S&P 500 Pure Value | 84 |
| 15 | DSTL | Distillate US Fundamental Stability & Value | 83 |
| 16 | GRPM | Invesco S&P MidCap 400 GARP | 83 |
| 17 | HERD | Pacer Cash Cows Fund of Funds | 83 |
| 18 | FPA | First Trust Asia Pacific Ex-Japan AlphaDEX | 82 |
| 19 | SIXS | ETC 6 Meridian Small Cap Equity | 82 |
| 20 | JPEM | JPMorgan Diversified Return EM Equity | 81 |
| 21 | FJP | First Trust Japan AlphaDEX | 81 |
| 22 | TPFC | Timothy Plan Free Cash Flow | 81 |
| 23 | FNK | First Trust Mid Cap Value AlphaDEX | 80 |
| 24 | LGCF | Themes US Cash Flow Champions | 80 |
(Full write-ups, metrics, and reasoning for each of these — plus the honorable-mention and low-confidence tiers — are in Parts 2 through 8 of this series.)
35. Frequently Asked Questions
How often should I re-run a screen like this?
I revisit fundamentals like these on a quarterly basis at minimum, since P/E, P/S, and P/B shift with both price moves and earnings updates. Growth rates (sales, cash flow, book value) typically update alongside quarterly or annual filings. A fund scoring 89 today could easily be a 75 in six months if its price runs up faster than its fundamentals — confidence scores are a snapshot, not a permanent label.
Should I sell everything and buy only the top-ranked ETFs?
No. This framework is one lens — fundamental valuation and growth — not a complete investment plan. It doesn't account for your personal tax situation, time horizon, existing holdings, or risk tolerance. Selling long-held positions to chase a higher-scoring fund can trigger capital gains taxes that outweigh any fundamental edge. Use this as a screening tool to evaluate new capital or as one input among several, not a signal to overhaul an existing portfolio overnight.
Why do free-cash-flow ETFs dominate the top of the list?
Because free cash flow is one of the hardest financial metrics to manipulate through accounting choices, and funds explicitly screening for strong, growing free cash flow tend to select for genuinely healthy businesses rather than merely "statistically cheap" ones. That said, this is partly a reflection of current market conditions — cash-flow strategies have been in favor recently, which is part of why their fundamentals currently look so attractive relative to their price.
What about expense ratios, tax efficiency, and trading volume?
Deliberately outside the scope of this series. This was purely a fundamental valuation-and-growth screen. Before investing in any fund mentioned here, check its expense ratio, average daily volume, bid-ask spread, and — if applicable — its tax treatment (some funds, particularly options-income and buffer strategies, have meaningfully different tax profiles than plain index funds).
Are the leveraged and single-country funds always bad?
Not always — for short-term tactical trades or hedging, leveraged products serve a real purpose. For single-country funds, if you have a specific, well-researched thesis on a particular market, concentrated exposure can make sense. My low confidence scores reflect their fit for a long-term, fundamentals-based core holding — not a judgment on every possible use case.
36. Closing Thoughts
Over the course of this series, one pattern held up again and again, across every single category I looked at: the funds that combined a genuine valuation discount with verifiable, durable growth consistently outscored funds that were merely cheap, merely popular, or merely flashy on one headline metric. That combination — cheap and growing — is rarer than it sounds, and it's exactly why disciplined screening across all six metrics matters more than fixating on any single number.
The other lesson worth carrying forward: skepticism is part of the process, not an obstacle to it. Some of the most useful moments in this series weren't finding a great fund — they were catching a fund that looked great on paper (Turkey's growth numbers, FXO's cash flow spike, GAA's sales figure) and recognizing the underlying data artifact before it became a costly mistake.
No comments:
Post a Comment